Recently, Chao et al. have reported the synergic effect of antibodies against CD47 with the therapeutic cancer antibody rituximab on the phagocytosis of non-Hodgkin lymphoma by macrophages in immune-deficient mice [39]. This evidence concerns the gene CD47 and non-Hodgkin lymphoma.